AAP urges pediatricians to prescribe buprenorphine

In “Medication‐Assisted Treatment of Adolescents With Opioid Use Disorders,” published online August 22, the American Academy of Pediatrics (AAP) urges its members to make buprenorphine available to patients with opioid use disorders. A leading cause of morbidity and mortality among youth in the United States, opioid use disorders have effective treatments, both medications (methadone, buprenorphine, and naltrexone) and counseling, but access to appropriate treatment is restricted, especially for adolescents. The AAP noted that resources are needed to communicate information about the effective treatments, as well as to develop new treatment especially for this age group.
Source: The Brown University Child and Adolescent Psychopharmacology Update - Category: Psychiatry Tags: Opioid Use Disorders Source Type: research